Mild form of Maroteaux-Lamy syndrome: Corneal histopathology and ultrastructure

Cornea

Volumn 17, Issue 6, 1998, Pages 664-668

  Laver, Nora M V ^a   Friedlander, Miles H ^b   McLean, Ian W ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cornea; Histopathology; Maroteaux Lamy syndrome; Mild type; Ultrastructure

Indexed keywords

ADULT; ARTICLE; CASE REPORT; COLLAGEN DEGRADATION; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAOCULAR PRESSURE; MAROTEAUX LAMY SYNDROME; PENETRATING KERATOPLASTY; PRIORITY JOURNAL;

EID: 0031729576     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-199811000-00015     Document Type: Article

References (25)

1. Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. New York: McGraw-Hill, 1989:1565-87.
2. Beck M, Spranger J. Mucopolysaccharides and oligosaccharides. In: Fernandas J, Saudubray J-M, Van der Berghe G, eds. Inborn metabolic diseases: diagnosis and treatment. Berlin: Springer-Verlag, 1996:383-8.
3. Sugar J. Corneal manifestations of the systemic mucopolysaccharidoses. Ann Ophthalmol 1979;11:531-5.
4. Maroteaux P, Lamy M. Hurler's disease, Morquio's disease and related mucopolysaccharidoses. J Pediatr 1965;67:312.
5. Maroteaux P, Lamy P. La pseudo-polydystrophie de Hurler. Presse Med 1966;74:2889.
6. Isbrant D, Arlt G, Brooks DA, Hopwood JJ, von Figura K, Peters C. Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): six unique arylsulfatase B gene alleles causing variable disease phenotypes. Am J Hum Genet 1994;54:454-63.
7. Litjens T, Brooks DA, Peters C, Gibson GJ, Hopwood JJ. Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients. Am J Hum Genet 1996;58: 1127-34.
8. Fluharty AL, Stevens RL, Sanders DL, Kihara H. Arylsulfatase B deficiency in Maroteaux-Lamy syndrome cultured fibroblasts. Biochem Biophys Res Commun 1974;59(2):455-61.
9. Shapira E, DeGregorio RR, Malaton R, Nadler Hl. Reduced arylsulfatase B activity of the mutant enzyme protein in Maroteaux-Lamy syndrome. Biochem Biophys Res Commun 1975;62(2):448-55.
10. Goldberg MF, Scott CI, McKusick VA. Hydrocephalus and papilledema in the Maroteaux-Lamy syndrome (systemic mucopolysaccharidosis type VI). Am J Ophthalmol 1970;69:969-75.
11. Cantor LB, Disseler JA, Wilson FM. Glaucoma in the Maroteaux-Lamy syndrome. Am J Ophthalmol 1989;108:426-30.
12. Stürmer J. Mukopolysaccharidose Typ VI-A (Morbus Maroteaux-Lamy): klinisch-pathologischer Fallbericht. Klin Monatsbl Augenheilkd 1989;194:273-81.
13. Tamaki N, Kojima N, Tanimoto M, Suyama T, Matsumoto S. Myelopathy due to diffuse thickening of the cervical dura mater in Maroteaux-Lamy syndrome: report of a case. Neurosurgery 1987; 21(3):416-9.
14. Schwartz MF, Werbin TP, Green WR. Occurrence of mucopolysaccharides in corneal grafts in the Maroteaux-Lamy syndrome. Cornea 1985;4:58-66.
15. Quigley HA, Kenyon KR. Ultrastructural and histochemical studies of a newly recognized form of systemic mucopolysaccharidosis (Maroteaux-Lamy syndrome, mild phenotype). Am J Ophthalmol 1974;77:809-18.
16. Varsano D, Cohen EJ, Nelson LB, Eagle RC Jr. Corneal transplantation in Maroteaux-Lamy syndrome. Arch Ophthalmol 1997;115 (3):428-9.
17. Nauman GOH, Rummelt V. Aufklaren der transplantatnahen Wirtshornhaut nach perforierender Keratoplastik beim Maroteaux-Lamy-Syndrom (Mukopolysaccharidose Typ VI-A). Klin Monatsbl Augenheilkd 1993;203:351-60.
18. Süveges I. Histological and ultrastructural studies of the cornea in Maroteaux-Lamy syndrome. Graefes Arch Clin Exp Ophthalmol 1979;212:29-39.
19. Kenyon KR, Topping TM, Green RW, Maumenee AE. Ocular pathology of the Maroteaux-Lamy syndrome (systemic mucopolysaccharidosis type VI): histologic and ultrastructural report of two cases. Am J Ophthalmol 1972;73:718-41.
20. Jezyk PF, Haskins ME, Patterson DF, Mellman WJ, Greenstein M. Mucopolysaccharidosis in a cat with arylsulfatase B deficiency: a model of Maroteaux-Lamy syndrome. Science 1977;198:834-6.
21. Gasper PW, Thrall MA, Wenger DA, et al. Correction of feline arylsulfatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation. Nature 1984;312:467-9.
22. Crawley AC, Brooks DA, Muller VJ, et al. Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome. J Clin Invest 1996;97(8):1864-73.
23. Aguirre G, Raver I, Yanoff M, Haskins M. Reciprocal corneal transplantation fails to correct mucopolysaccharidosis VI corneal storage. Invest Ophthalmol Vis Sci 1992;33:2702-13.
24. McGovern MM, Ludman MD, Short MP, et al. Bone marrow transplantation in Maroteaux-Lamy syndrome (MPS type 6): a status 40 months after BMT. Birth Defects 1986;22(1):41-53.
25. Imaizumi M, Gushi K, Kurobane I, et al. Long-term effects of bone marrow transplantation for inborn errors of metabolism: a study of four patients with lysosomal storage diseases. Acta Paediatr Jpn 1994;36(1):30-6.